Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Inflammatory markers (CRP, fibrinogen) in lung transplant recipients during cellular rejection

S Zeglen, J Wojarski, E Wozniak-Grygiel, R Buldak, J Nozynski, E Herczakowska, H Czarnecka, E Kucewicz-Czech

Ann Transplant 2009; 14(1): 61-61 :: ID: 880426

Abstract

Background: Despite new immunosuppression protocols, cellular rejection has still an impact on survival after lung transplantation (LTx). The aim of the study was to analyse unspecific inflammatory markers like C-reactive protein (CRP) and fibrinogen in the context of cellular rejection.
Material/Methods: The study group included 7 LTx patients (2 women and 5 men, mean age 43.6±12.1 yr, BMI 21.0±7.1) at rejection periods (n=10) before and after methylprednisolonum administration (group A and B, respectively). The control group (group C) included 10 lung transplant recipients (3 women and 7 men, mean age 46.6±14.5 yr, BMI 18.2±3.0) at clinically stable period. Serum CRP levels were measured using a commercially available kit with the turbidimetric method and fibrinogen levels were measured by routine Clauss method.
Results: Intriguingly, no significant differences in average CRP values between analyzed groups were found (average CRP value of group C, A and B was 40.5±42.4, 42.3±52.0, 32.8±28.5; respectively). Significantly increased average fibrinogen value in group B was revealed when compared to group C (662.3±27.8 vs. 490.0±128.3, p<0.05; respectively).
Conclusions: Non-invasive diagnosis of acute cellular rejection in lung transplantation recipients is extremely difficult. Higher fibrinogen concentrations might be associated with increased risk of rejection.

Keywords: Lung Transplantation

Add Comment 0 Comments

In Press

Original article  

Effect of Medical Accessibility on Long-Term Survival in Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.944839  

Original article  

Lung Transplant Success in COVID-19 Patients Requiring V-V ECMO: One-Year Follow-Up

Ann Transplant In Press; DOI: 10.12659/AOT.946088  

Most Viewed Current Articles

05 Apr 2022 : Original article   13,221

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   10,677

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   9,822

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   7,535

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358